- Home
- TECX vs PFL Comparison
TECX vs PFL Comparison
Compare TECX & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- PFL
- Stock Information
- Founded
- TECX 2019
- PFL 2003
- Country
- TECX United States
- PFL United States
- Employees
- TECX N/A
- PFL N/A
- Industry
- TECX
- PFL Finance Companies
- Sector
- TECX
- PFL Finance
- Exchange
- TECX Nasdaq
- PFL Nasdaq
- Market Cap
- TECX 334.4M
- PFL 375.4M
- IPO Year
- TECX 2018
- PFL N/A
- Fundamental
- Price
- TECX $19.81
- PFL $8.26
- Analyst Decision
- TECX Buy
- PFL
- Analyst Count
- TECX 7
- PFL 0
- Target Price
- TECX $78.67
- PFL N/A
- AVG Volume (30 Days)
- TECX 156.7K
- PFL 113.7K
- Earning Date
- TECX 08-13-2025
- PFL 01-01-0001
- Dividend Yield
- TECX N/A
- PFL 11.53%
- EPS Growth
- TECX N/A
- PFL N/A
- EPS
- TECX N/A
- PFL N/A
- Revenue
- TECX N/A
- PFL N/A
- Revenue This Year
- TECX N/A
- PFL N/A
- Revenue Next Year
- TECX N/A
- PFL N/A
- P/E Ratio
- TECX N/A
- PFL N/A
- Revenue Growth
- TECX N/A
- PFL N/A
- 52 Week Low
- TECX $13.70
- PFL $6.98
- 52 Week High
- TECX $61.07
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- TECX 40.56
- PFL 44.50
- Support Level
- TECX $22.13
- PFL $8.30
- Resistance Level
- TECX $25.75
- PFL $8.40
- Average True Range (ATR)
- TECX 1.44
- PFL 0.04
- MACD
- TECX -0.48
- PFL -0.01
- Stochastic Oscillator
- TECX 10.68
- PFL 12.50
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.